PubRank

P Duriez

Author PubWeight™ 53.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 1999 6.41
2 Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis. J Biol Chem 1997 1.88
3 Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ Res 1999 1.82
4 Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Curr Opin Lipidol 1999 1.62
5 PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochem Soc Trans 2006 1.44
6 [Diffuse hamartoma of the arrector muscles and congenital hypertrichosis lanuginosa]. Ann Dermatol Venereol 1991 1.39
7 Mutator natural Escherichia coli isolates have an unusual virulence phenotype. Infect Immun 2001 1.37
8 Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner. FEBS Lett 2000 1.28
9 PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages. Circulation 2001 1.12
10 The role of fibric acids in atherosclerosis. Curr Atheroscler Rep 2001 1.09
11 Apolipoprotein B metabolism in homozygous familial hypercholesterolemia. J Lipid Res 1989 1.09
12 Peroxisome proliferator-activated receptor activators inhibit oxidized low-density lipoprotein-induced endothelin-1 secretion in endothelial cells. J Cardiovasc Pharmacol 2002 0.95
13 Antioxidant properties of di-tert-butylhydroxylated flavonoids. Free Radic Biol Med 2000 0.93
14 Bcl-2 acts upstream of the PARP protease and prevents its activation. Cell Death Differ 1997 0.92
15 Hawthorn extracts inhibit LDL oxidation. Pharmazie 2003 0.89
16 Low-density lipoprotein for delivery of an acrylophenone antineoplastic molecule into malignant cells. Cancer Res 1992 0.88
17 Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease. Clin Chim Acta 1995 0.88
18 High density lipoproteins and coronary heart disease. Future prospects in gene therapy. Biochimie 1998 0.87
19 Livestock waste treatment systems for reducing environmental exposure to hazardous enteric pathogens: some considerations. Bioresour Technol 2008 0.86
20 Quantification of apolipoprotein C-III in serum by a noncompetitive immunoenzymometric assay. Clin Chem 1985 0.86
21 [Wegener's granulomatosis with urethral-penile location. Apropos of a case]. Ann Urol (Paris) 1990 0.86
22 Modified low density lipoproteins activate human macrophages to secrete immunoreactive endothelin. FEBS Lett 1991 0.84
23 Rapid quantification of alpha-tocopherol in plasma and low- and high-density lipoproteins. Clin Chem 1996 0.83
24 Preformed PAF-acether and lyso PAF-acether are bound to blood lipoproteins. FEBS Lett 1988 0.83
25 Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits. Biochem Biophys Res Commun 2000 0.82
26 Paraoxonase polymorphism (Gln192Arg) as a determinant of the response of human coronary arteries to serotonin. Circulation 2000 0.81
27 Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty. Clin Chim Acta 2000 0.81
28 PPARs: a new target for neuroprotection. J Neurol Neurosurg Psychiatry 2006 0.81
29 PPARS, metabolic disease and atherosclerosis. Pharmacol Res 2001 0.80
30 [Molecular mechanism of action of the fibrates]. J Soc Biol 1999 0.79
31 Alpha-tocopherol but not beta-tocopherol inhibits thrombin-induced PKC activation and endothelin secretion in endothelial cells. J Cardiovasc Risk 1999 0.79
32 Malignant blue nevus: three new cases and a review of the literature. Ann Plast Surg 1998 0.79
33 Structure-activity relationships in a series of melatonin analogues with the low-density lipoprotein oxidation model. Free Radic Biol Med 1999 0.79
34 Phenylpropanoids from Ballota nigra L. inhibit in vitro LDL peroxidation. Phytother Res 2000 0.79
35 Effect of the inflammation, chronic hyperglycemia, or malabsorption on the apolipoprotein A-IV concentration in type 1 diabetes mellitus and in diabetes secondary to chronic pancreatitis. Metabolism 2001 0.78
36 Apo B-containing lipoprotein particles in poorly controlled insulin-dependent diabetes. Atherosclerosis 1996 0.78
37 [Erythema elevatum diutinum associated with pyoderma gangrenosum in an HIV-positive patient]. Ann Dermatol Venereol 2010 0.78
38 Enhancement of all-trans-retinoic acid efficiency in granulocytic differentiation of HL-60 cells by incorporation into low density lipoprotein. Int J Oncol 1998 0.78
39 Association between epitopes detected by monoclonal antibody BIP-45 and the XbaI polymorphism of apolipoprotein B. Clin Genet 1988 0.78
40 [Breastfeeding: opinion and knowledge of pharmacists. A study in a semi-urban territory]. Arch Pediatr 2012 0.77
41 4-Mercaptoimidazoles derived from the naturally occurring antioxidant ovothiols 1. Antioxidant properties. Free Radic Res 2000 0.77
42 Apolipoprotein B immunochemical heterogeneity in dialysed patients with chronic renal failure and patients with coronary artery stenosis. Am J Nephrol 1989 0.77
43 Paraoxonase activity is dramatically decreased in patients positive for anticardiolipin antibodies. Lupus 2000 0.77
44 Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia. Clin Sci (Lond) 2001 0.76
45 Evolution pattern of auto-antibodies against oxidized low-density lipoproteins in renal transplant recipients. Nephron 2001 0.76
46 [New concepts on the mechanism of action of fibrates and therapeutic prospectives in atherosclerosis]. Bull Acad Natl Med 2001 0.76
47 Endothelial derived vasorelaxation is impaired in human APO A-I transgenic rabbits. Biochem Biophys Res Commun 1997 0.76
48 Fatty acid abnormalities in chronic pancreatitis: effect of concomitant diabetes mellitus. Eur J Clin Nutr 2003 0.76
49 Apolipoprotein-AI-containing particles and atherosclerosis. Isr J Med Sci 1996 0.76
50 A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells. J Cardiovasc Pharmacol 1998 0.75
51 A therapeutic dosage (3 g/day) of borage oil supplementation has no effect on platelet aggregation in healthy volunteers. Fundam Clin Pharmacol 1997 0.75
52 AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations. J Hum Virol 1999 0.75
53 [Tricuspid insufficiency disclosing carcinoid syndrome]. Rev Med Interne 1994 0.75
54 [Clinical polymorphism of lupus erythematosus]. Ann Dermatol Venereol 1991 0.75
55 Differential toxicities of air (mO-LDL) or copper-oxidized LDLs (Cu-LDL) toward endothelial cells. J Biochem Mol Toxicol 1999 0.75
56 [Contribution of transesophageal echocardiography in the investigation of the atrium in systemic embolism]. Ann Med Interne (Paris) 1992 0.75
57 [Reverse cholesterol transport and use of transgenic mice and rabbits to reveal candidate genes for protection against atherosclerosis]. Bull Acad Natl Med 1998 0.75
58 Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group. Am J Cardiol 1995 0.75
59 [Isolated stenosis of the popliteal artery after treatment with methysergide. An anatomopathologic study]. J Mal Vasc 1990 0.75
60 [Fundamental data on atherosclerosis]. Ann Endocrinol (Paris) 2001 0.75
61 [Study of the protein profile of the Adélé tribe of Togo]. Sante 2001 0.75
62 Comparison of the effect of fluvastatin, an hydroxymethyl glutaryl coenzyme A reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by apolipoprotein composition. Metabolism 1995 0.75
63 [Severe contact dermatitis caused by mephenesin]. Ann Dermatol Venereol 1996 0.75
64 Quantitative determination of human plasma apolipoprotein A-II by a non competitive enzyme-linked immunosorbent assay. J Immunoassay 1986 0.75
65 [Anti-cholesterol agents, new therapeutic approaches]. Ann Pharm Fr 2004 0.75
66 [The important role of apolipoprotein C-III in lipoprotein metabolism]. C R Seances Soc Biol Fil 1995 0.75
67 Lipoprotein particles in homozygous familial hypercholesterolemic patients treated with portacaval shunt and LDL apheresis. Clin Chim Acta 1990 0.75
68 Preparation of anti-HIV-low-density lipoprotein complexes for delivery of anti-HIV drugs via the low-density lipoprotein pathways. Biotechnol Ther 1994 0.75
69 [Arterial hypertension in Thio (New Caledonia)]. Med Trop (Mars) 1991 0.75
70 [Coronary angioplasty using 5 or 6 F guide catheters. Results of a comparative, monocentric, prospective randomized study]. Arch Mal Coeur Vaiss 2003 0.75
71 [Administrative aspects of specialized prevention]. Rev Neuropsychiatr Infant 1977 0.75
72 Di-tert-butylhydroxylated flavonoids protect endothelial cells against oxidized LDL-induced cytotoxicity. J Biochem Mol Toxicol 2001 0.75
73 [National liaison committee of clubs and teams of specialized prevention]. Rev Neuropsychiatr Infant 1977 0.75
74 [Intrathoracic textiloma after cardiac surgery. Apropos of a case]. Arch Mal Coeur Vaiss 1996 0.75
75 [Deterged large abscess of the aortic valve ring disclosed after infective endocarditis]. Arch Mal Coeur Vaiss 1994 0.75
76 [Genes, dyslipoproteinemias and atherosclerosis: from the experimental to the therapeutic]. Ann Endocrinol (Paris) 1999 0.75
77 Oxidized low density lipoproteins exert arrhythmogenic effects in rabbit Purkinje fibers. Biochem Biophys Res Commun 1992 0.75
78 Monocyte tissue factor response is decreased in patients with hyperlipidemia. Thromb Res 1999 0.75
79 Apolipoprotein B polymorphism and altered apolipoprotein B concentrations in Congolese blacks. Clin Genet 1991 0.75
80 Detection of human apolipoprotein B polymorphic species with one monoclonal antibody (BIP 45) against low density lipoprotein. Influence of this polymorphism on lipid levels and coronary artery stenosis. Atherosclerosis 1987 0.75
81 Oxidized high-density lipoproteins modulate endothelin secretion by adult bovine aortic endothelial cells. J Cardiovasc Risk 1995 0.75
82 [Coronary vessel ectasia: coronary artery disease with a high thromboembolic risk]. Ann Cardiol Angeiol (Paris) 1998 0.75